Overview

Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis

Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cell(hUC-MSC) for Rheumatoid Arthritis.
Phase:
Phase 1
Details
Lead Sponsor:
Shenzhen Hornetcorn Bio-technology Company, LTD
Collaborator:
Futian People's Hospital
Treatments:
Antirheumatic Agents
Methotrexate